Avita signs $30m contract expansion

21/09/2017 - 15:09

Health technology company Avita Medical has signed a $US24.3 million ($A30.5 million) expansion to its contract with a US government research agency, for further funding of its ReCell device trials.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options